These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35505478)

  • 1. Cost of TB prevention and treatment in the Philippines in 2017.
    Capeding TPJ; Rosa JD; Lam H; Gaviola DG; Garfin AMC; Hontiveros C; Cunnama L; Laurence YV; Kitson N; Vassall A; Sweeney S; Garcia-Baena I
    Int J Tuberc Lung Dis; 2022 May; 26(5):392-398. PubMed ID: 35505478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of TB services in India (No 1).
    Chatterjee S; Toshniwal MN; Bhide P; Sachdeva KS; Rao R; Laurence YV; Kitson N; Cunnama L; Vassall A; Sweeney S; Baena IG
    Int J Tuberc Lung Dis; 2021 Dec; 25(12):1013-1018. PubMed ID: 34886932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of TB services in healthcare facilities in Kenya (No 3).
    Kairu A; Orangi S; Oyando R; Kabia E; Nguhiu P; Ong Ang O J; Mwirigi N; Laurence YV; Kitson N; Garcia Baena I; Vassall A; Barasa E; Sweeney S; Cunnama L
    Int J Tuberc Lung Dis; 2021 Dec; 25(12):1028-1034. PubMed ID: 34886934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug Resistant Mycobacterium tuberculosis Among Military and Civilian Personnel seen at a Tertiary Military Hospital, Manila, Philippines (2015-2018).
    Velasco JM; Gaurano N; Valderama MT; Nogrado K; Diones PC; Lopez MN; Liao C; Chua D; Develos M; Fernandez S; Macareo L; Swierczewski B
    Mil Med; 2020 Aug; 185(7-8):e1106-e1111. PubMed ID: 31915831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India.
    Muniyandi M; Lavanya J; Karikalan N; Saravanan B; Senthil S; Selvaraju S; Mondal R
    Int Health; 2021 Dec; 13(6):536-544. PubMed ID: 33570132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
    Diel R; Nienhaus A; Hillemann D; Richter E
    Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
    Gomez GB; Siapka M; Conradie F; Ndjeka N; Garfin AMC; Lomtadze N; Avaliani Z; Kiria N; Malhotra S; Cook-Scalise S; Juneja S; Everitt D; Spigelman M; Vassall A
    BMJ Open; 2021 Dec; 11(12):e051521. PubMed ID: 34862287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of decentralised care model for managing MDR-TB in India.
    John D; Chatterjee P; Murthy S; Bhat R; Musa BM
    Indian J Tuberc; 2018 Jul; 65(3):208-217. PubMed ID: 29933862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
    van Rensburg C; Berhanu R; Hirasen K; Evans D; Rosen S; Long L
    PLoS One; 2019; 14(6):e0217820. PubMed ID: 31170207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing laboratory costs of smear/culture and Xpert
    Naidoo P; Dunbar R; du Toit E; van Niekerk M; Squire SB; Beyers N; Madan J
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1377-1385. PubMed ID: 27725051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries.
    Lu X; Smare C; Kambili C; El Khoury AC; Wolfson LJ
    BMC Health Serv Res; 2017 Jan; 17(1):87. PubMed ID: 28122562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of TB services: approach and summary findings of a multi-country study (Value TB).
    Sweeney S; Laurence YV; Cunnama L; Gomez GB; Garcia-Baena I; Bhide P; Capeding TJ; Chatterjee S; Chikovani I; Eyob H; Kairu A; Terefe MM; Shengelia N; Toshniwal M; Saadi N; Bergren E; Vassall A
    Int J Tuberc Lung Dis; 2022 Nov; 26(11):1006-1015. PubMed ID: 36281042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of TB service provision in the public and private health sectors in Ethiopia.
    Minwyelet Terefe M; Eyob H; Letta T; Nadew E; Assefa T; Hailu B; Cunnama L; Garcia Baena I; Vassall A; Sweeney S; Laurence YV
    Int J Tuberc Lung Dis; 2022 Dec; 26(12):1128-1136. PubMed ID: 36447315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Methodological Variation in Healthcare Provider Perspective Tuberculosis Costing Papers Conducted in Low- and Middle-Income Settings, Using An Intervention-Standardised Unit Cost Typology.
    Cunnama L; Gomez GB; Siapka M; Herzel B; Hill J; Kairu A; Levin C; Okello D; DeCormier Plosky W; Garcia Baena I; Sweeney S; Vassall A; Sinanovic E
    Pharmacoeconomics; 2020 Aug; 38(8):819-837. PubMed ID: 32363543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    Bada FO; Blok N; Okpokoro E; Dutt S; Akolo C; Dakum P; Abimiku A
    PLoS One; 2020; 15(12):e0241065. PubMed ID: 33259492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.
    Naidoo P; du Toit E; Dunbar R; Lombard C; Caldwell J; Detjen A; Squire SB; Enarson DA; Beyers N
    PLoS One; 2014; 9(7):e103328. PubMed ID: 25079599
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.